A multicenter, non-interventional study to evaluate the disease activity in Multiple Sclerosis after withdrawal of Natalizumab in Portugal

Overview of attention for article published in Clinical Neurology & Neurosurgery, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 13 X users

Readers on

mendeley: 24 Mendeley

Summary X

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 25,806 followers.

New NNT→A multicenter, non-interventional study to evaluate the disease activity in Multiple Sclerosis after withdrawal of Natalizumab in Portugal. https://t.co/Kqh4TEHuwk

24 Oct 2020

Reply Repost Favourite

RT @Brandon_Beaber: Stopping natalizumab (Tysabri) can result in MS disease rebound activity after a median time of about 20 weeks. Genera…

20 Jul 2019

Reply Repost Favourite

RT @Brandon_Beaber: Stopping natalizumab (Tysabri) can result in MS disease rebound activity after a median time of about 20 weeks. Genera…

19 Jul 2019

Reply Repost Favourite

RT @Brandon_Beaber: Stopping natalizumab (Tysabri) can result in MS disease rebound activity after a median time of about 20 weeks. Genera…

18 Jul 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.